Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Immunogenicity and protective efficacy of a dual subunit vaccine against respiratory syncytial virus and influenza virus.

Park MH, Chang J.

Immune Netw. 2012 Dec;12(6):261-8. doi: 10.4110/in.2012.12.6.261. Epub 2012 Dec 31.

2.

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.

Kim S, Jang JE, Yu JR, Chang J.

Vaccine. 2010 May 14;28(22):3801-8. doi: 10.1016/j.vaccine.2010.03.032. Epub 2010 Mar 31.

PMID:
20362203
3.

Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.

Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE Jr.

J Virol. 2007 Dec;81(24):13710-22. Epub 2007 Oct 10.

4.

Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant.

Kim S, Joo DH, Lee JB, Shim BS, Cheon IS, Jang JE, Song HH, Kim KH, Song MK, Chang J.

PLoS One. 2012;7(2):e32226. doi: 10.1371/journal.pone.0032226. Epub 2012 Feb 27.

5.

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.

Power UF, Plotnicky-Gilquin H, Huss T, Robert A, Trudel M, Ståhl S, Uhlén M, Nguyen TN, Binz H.

Virology. 1997 Apr 14;230(2):155-66.

6.
7.

Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.

Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T.

Biochem Biophys Res Commun. 2009 Apr 17;381(4):528-32. doi: 10.1016/j.bbrc.2009.02.075. Epub 2009 Feb 20.

PMID:
19233131
8.

Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).

Cheon IS, Shim BS, Park SM, Choi Y, Jang JE, Jung DI, Kim JO, Chang J, Yun CH, Song MK.

PLoS One. 2014 Apr 15;9(4):e94269. doi: 10.1371/journal.pone.0094269. eCollection 2014.

9.

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

Cusi MG, Zurbriggen R, Correale P, Valassina M, Terrosi C, Pergola L, Valensin PE, Glück R.

Vaccine. 2002 Oct 4;20(29-30):3436-42.

PMID:
12297388
10.

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.

Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.

Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.

12.

Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.

Huang Y, Cyr SL, Burt DS, Anderson R.

J Clin Virol. 2009 Apr;44(4):287-91. doi: 10.1016/j.jcv.2009.01.009. Epub 2009 Feb 23.

PMID:
19233722
15.
16.

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

Tebbey PW, Scheuer CA, Peek JA, Zhu D, LaPierre NA, Green BA, Phillips ED, Ibraghimov AR, Eldridge JH, Hancock GE.

Vaccine. 2000 Jun 1;18(24):2723-34.

PMID:
10781860
17.
18.

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

Tamura S, Samegai Y, Kurata H, Nagamine T, Aizawa C, Kurata T.

Vaccine. 1988 Oct;6(5):409-13.

PMID:
2848377
20.

Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.

Shafique M, Wilschut J, de Haan A.

Vaccine. 2012 Jan 11;30(3):597-606. doi: 10.1016/j.vaccine.2011.11.054. Epub 2011 Nov 24.

PMID:
22120195

Supplemental Content

Support Center